Ong, C T <br/><br/>
mTOR as a potential therapeutic target for treatment of keloids and excessive scars.  [electronic resource] 

 -  Experimental dermatology  May 2007 
 - 394-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0906-6705 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0625.2007.00550.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Adolescent<br/>Adult<br/>Cells, Cultured<br/>Child<br/>Cicatrix, Hypertrophic--drug therapy<br/>Collagen--metabolism<br/>Cyclin D<br/>Cyclins--metabolism<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fibroblasts--drug effects<br/>Fibronectins--metabolism<br/>Humans<br/>In Vitro Techniques<br/>Keloid--drug therapy<br/>Male<br/>Phosphorylation<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Protein Kinases--drug effects<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Sirolimus--administration & dosage<br/>TOR Serine-Threonine Kinases